A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

She had made repeated visits to the GP with symptoms, which over the following years became persistent and gradually worse.

Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors.

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

One woman opens up about her experience with clitoral atrophy after being diagnosed with breast cancer. Here's how she found ...

A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding ...

Patients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab ...

New research led by scientists in Ireland has uncovered how a fat-rich fluid found in the abdomen of ovarian cancer patients ...

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...